Arab Drug is an Egyptian company engaged in the pharmaceutical sector.
26.01.2023
|
News by
Zawya
The new plant was built on an area of 15,527 square meters and its investment is close to one billion Egyptian pounds last year.
25.01.2023
|
News by
asumetech
Nile Pharma manufactures and markets pharmaceuticals.
24.01.2023
|
News by
Zawya
Dr. George said that the sector’s exports achieved an increase of 200% compared to 2019 exports before the Coronavirus pandemic.
24.01.2023
|
News by
See news
Following the recent releases, the country's strategic drug reserve rose to 6-12 months.
17.01.2023
|
News by
Ahram Online
Pfizer Egypt team will share with the students of the Faculty of Pharmacy at FUE the latest expertise in the pharmaceutical market.
13.01.2023
|
News by
Zawya
The company’s net profit after tax jumped to EGP 71.283 million in July-November from EGP 59.908 million the year before.
12.01.2023
|
News by
Zawya
Accordingly, the company’s issued capital will increase to EGP 252.113 million from EGP 250 million.
10.01.2023
|
News by
Arab Finance
The African market is promising for the sector's products during 2023, but some obstacles must be dealt with.
08.01.2023
|
News by
See news
In June 2022, VACSERA settled debts of EGP 712.5 million for National Investment Bank, the report showed.
06.01.2023
|
News by
Arab Finance
Celltrion Healthcare will handle the development, manufacturing and supply of Vegzelma and Hikma will handle the commercialization.
05.01.2023
|
News by
Zawya
The minister discussed cooperation with the MSD company to provide the latest oncological treatments (immunotherapy) for breast cancer patients.
04.01.2023
|
News by
Daily News Egypt
Moreover, exports of medical industries rose by 11.30% YoY during January-August 2022 to reach $69 million from $62 million.
20.12.2022
|
News by
Zawya
Producing medicines locally would reduce the import bill, absorb pharmacy and science graduates, and provide medicine on time.
18.12.2022
|
News by
Egypt Independent
Under the partnership, the distribution of insulin to middle- and low-income countries—most of them in Africa—is expected to begin in 18 months.
15.12.2022
|
News by
Fierce Pharma
Egypt has no shortage in medicinal drugs and that local companies fulfill 90 percent of needs.
14.12.2022
|
News by
Egypt Today
The company’s operating revenues rose to EGP 464.415 million in the July-October period of FY 2022/2023.
13.12.2022
|
News by
Zawya
Revenues soared to EGP 1.163 billion in nine months to September 30th from EGP 630.477 million the year before.
03.12.2022
|
News by
Zawya
Pfizer announced its success in providing the latest treatments to 7 million patients in Egypt, and its goal to reach 7.6 million end of year.
03.12.2022
|
News by
Zawya
The agreement is for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech.
29.11.2022
|
News by
B3C News
